NCT04230954 2022-06-07
Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
University of South Alabama
Phase 2 Terminated
Clinical Trials
3 trialsNCT00570674 2017-11-13
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Dana-Farber Cancer Institute
Phase 1/2 Terminated
NCT01363466 2011-06-01
Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
UNICANCER
Phase 3 Terminated